![Danny Gagné](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Danny Gagné
Directeur/Membre du Conseil chez
ILKOS THERAPEUTICS, Inc.
Profil
Danny Gagné is currently a Director at ILKOS THERAPEUTICS, Inc. and a Portfolio Manager at Fonds de Solidarité FTQ since 2002.
He was previously a Director at Bioxel Pharma, Inc. in 2008.
Mr. Gagné received his undergraduate and graduate degrees from HEC Montréal.
Postes actifs de Danny Gagné
| Sociétés | Poste | Début |
|---|---|---|
Fonds de Solidarité FTQ
 Fonds de Solidarité FTQ Investment ManagersFinance FTQ invests in companies located in Canada, primarily in Montreal. The firm targets companies operating in the fields of manufacturing, distribution, technology, real estate and service sectors. It provides equity or debt financing for growth stage capital requirements with an investment size of up to CAD 5 million. It also takes minority and controlling interests. | Private Equity Investor | 01/01/2002 |
ILKOS THERAPEUTICS, Inc.
 ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology Operates biotechnology company | Directeur/Membre du Conseil | - |
Anciens postes connus de Danny Gagné
| Sociétés | Poste | Fin |
|---|---|---|
Bioxel Pharma, Inc.
 Bioxel Pharma, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Directeur/Membre du Conseil | 01/01/2008 |
Formation de Danny Gagné
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Bioxel Pharma, Inc.
Bioxel Pharma, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
Fonds de Solidarité FTQ
Fonds de Solidarité FTQ Investment ManagersFinance FTQ invests in companies located in Canada, primarily in Montreal. The firm targets companies operating in the fields of manufacturing, distribution, technology, real estate and service sectors. It provides equity or debt financing for growth stage capital requirements with an investment size of up to CAD 5 million. It also takes minority and controlling interests. | Finance |
HEC Montréal
 HEC Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ILKOS THERAPEUTICS, Inc.
ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology Operates biotechnology company | Health Technology |
